Last Updated on November 21, 2021 by The Health Master
Mumbai: Generic pharmaceutical company BDR Pharma launched generic drug Biapenem (BIAPEN) to treat patients with intra-abdominal infections, lower respiratory infections, or complicated urinary tract infections.
Biapenem, now available in the market, is a parenteral carbapenem antibacterial agent with a broad spectrum of in vitro antibacterial activity encompassing many gram-negative and gram-positive aerobic and anaerobic bacteria, including species producing β-lactamases.
Biapenem is more stable than Imipenem and Meropenem in being hydrolyzed by human renal dehydropeptidase-I (DHP-I) and therefore does not require the co-administration of a DHP-I inhibitor such as Cilastatin.
In addition, Biapenem is widely distributed and penetrates well into various tissues, including lung tissue) and body fluids, including sputum, pleural effusion, abdominal cavity fluid, amongst others.
Biapenem showed comparable clinical and bacteriological efficacy to Imipenem / Cilastatin for treating patients with intra-abdominal infections, lower respiratory infections or complicated urinary tract infections.
The product will be marketed under BDR pharma’s and its co-sponsor’s brand names. The dosage of BIAPEN will be available in 300 mg strength, much less in comparison to the Carbapenems dosage used to treat infections.
Natco Pharma launches FDC Trifluridine & Tipiracil first time in India
MSN Labs launches Vigabatrin Powder for the treatment of Epilepsy
A portable Hydrogen inhaler launched: Dual-use technology
Lupin launches generic Fenofibrate capsules for this ailment
Sun Pharma launches acne treatment cream
Dr Reddy’s Labs launches generic Ephedrine Sulfate injection
IPC to organize webinar on Key role of medical device industry…
Natco Pharma launches FDC Trifluridine & Tipiracil first time in India
Retired FDA officials are promoting Generic Drugs in innovative ways
No retention or renewal fees after one time registration of ASU products
International Conference on National Education Policy will be held at …
IPC adds new impurities and Reference Standards: Download the list
Drug alert: 36 out of 1061 samples declared as NSQ in October 2021
Latest Circulars by the Govt of India, Dept of Pharmaceuticals, Health…
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
